NDC 57319-455-27 - Thyrozine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
57319-455
Requested NDC
57319-455-27
Package NDCs from labels
57319-455-27, 57319-455-43
Manufacturer
PHOENIX PHARMACEUTICAL INC./ CLIPPER DISTRIBUTING, INC. | FIRST PRIORITY INCORPORATED
Effective date
2018-01-19
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Thyrozine PowderPHOENIX PHARMACEUTICAL INC./ CLIPPER DISTRIBUTING, INC. | FIRST PRIORITY INCORPORATED2018-01-19OTC ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
57319-455-27Thyrozine12 in 1 CASEPOWDER121
57319-455-27Thyrozine453.6 g in 1 JARPOWDER453.61
57319-455-43Thyrozine4536 g in 1 PAILPOWDER45361

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
57319-455THYROZINE (LEVOXINE) POWDER [PHOENIX PHARMACEUTICAL INC./ CLIPPER DISTRIBUTING, INC.]13 package rows20180120_a0920229-20ed-464d-b903-7405db88bd18.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSONESOURCE SPECIALTY PHARMA LIMITEDae9954a5-e196-449c-abea-ebe4afbee5172026-08-12Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSMAIA Pharmaceuticals, Inc.4e9adc35-3aba-4a0d-9c4e-7e7ee2ffdabd2026-08-05Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUMPiramal Critical Care, Inc.76139990-1355-cfb6-e053-2991aa0ace5b2025-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUMZydus Pharmaceuticals USA Inc.bf8a952c-f05b-4814-b55a-ed04be0152692025-09-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFosun Pharma USA Inc.3361138a-6e6f-e8df-e063-6294a90af2de2025-05-05Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSENDO USA, Inc.9d815416-11c9-470e-a82f-89b0bf232e122025-04-28Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLCce990712-49c1-4f66-9ee4-c770e8ec394c2025-04-17Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLC152d071f-d4aa-46d2-b397-61c1cabdd86d2024-10-14Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLCf88f44d8-2f18-4155-9d78-6323d19fbafe2024-10-14Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSSagent Pharmaceuticalsf57e9b19-6f17-4520-80fc-511322cc56c92023-10-19Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 054I36CPMN

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.